Cargando…

Dose-dependent impact of statin therapy intensity on circulating progenitor cells in patients undergoing percutaneous coronary intervention for the treatment of acute versus chronic coronary syndrome

BACKGROUND: By low-density lipoprotein (LDL) reduction, statins play an important role in cardiovascular risk modification. Incompletely understood pleiotropic statin effects include vasoprotection that might originate from mobilisation and differentiation of vascular progenitor cells. Data on the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Florescu, Roberta, Liehn, Elisa, Schaaps, Nicole, Schröder, Jörg, Almalla, Mohammad, Mause, Sebastian, Cornelissen, Anne, Vogt, Felix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119492/ https://www.ncbi.nlm.nih.gov/pubmed/35587929 http://dx.doi.org/10.1371/journal.pone.0267433

Ejemplares similares

Apolipoprotein E deficient rats generated via zinc-finger nucleases exhibit pronounced in-stent restenosis
por: Cornelissen, Anne, et al.
Publicado: (2019)

Engagement of the CXCL12–CXCR4 Axis in the Interaction of Endothelial Progenitor Cell and Smooth Muscle Cell to Promote Phenotype Control and Guard Vascular Homeostasis
por: Mause, Sebastian F., et al.
Publicado: (2022)

Apolipoprotein E4 Is Associated with Right Ventricular Dysfunction in Dilated Cardiomyopathy—An Animal and In-Human Comparative Study
por: Diaconu, Rodica, et al.
Publicado: (2021)

Effect of n-3 Polyunsaturated Fatty Acids on Regression of Coronary Atherosclerosis in Statin Treated Patients Undergoing Percutaneous Coronary Intervention
por: Ahn, Jinhee, et al.
Publicado: (2016)

Reduction of Circulating Endothelial Progenitor Cell Level Is Associated with Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary and Peripheral Interventions
por: Chiang, Chia-Hung, et al.
Publicado: (2014)

An unusual case of aortic metastasis from lung cancer
por: Diaconu, Rodica, et al.
Publicado: (2020)

Associations between endothelial progenitor cells, clinical characteristics and coronary restenosis in patients undergoing percutaneous coronary artery intervention
por: Montenegro, Fernando S., et al.
Publicado: (2018)

Effect of Previous Statin Therapy in Patients With Acute Coronary Syndrome and Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2011)

Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure
por: Cornelissen, Anne, et al.
Publicado: (2021)

Fibroblast Growth Factor 23 and Outcome Prediction in Patients with Acute Myocardial Infarction
por: Cornelissen, Anne, et al.
Publicado: (2022)

Effect of statins on coronary blood flow after percutaneous coronary intervention in patients with stable coronary artery disease
por: Cerit, L., et al.
Publicado: (2016)

Benefit of Early Statin Initiation within 48 Hours after Admission in Statin-Naïve Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Kim, Min Chul, et al.
Publicado: (2019)

Young coronary artery disease in patients undergoing percutaneous coronary intervention
por: Zuhdi, AS, et al.
Publicado: (2013)

Temporal Trends of High‐Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention
por: Bin Abdulhak, Aref A., et al.
Publicado: (2018)

Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins
por: Morales-Villegas, Enrique C., et al.
Publicado: (2011)

Effect of high-intensity statin preloading on TIMI flow in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2020)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Pham, Son V, et al.
Publicado: (2010)

Premedication to reduce anxiety in patients undergoing coronary angiography and percutaneous coronary intervention
por: Vlastra, Wieneke, et al.
Publicado: (2018)

Depression and Anxiety in patients undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
por: Mujtaba, Syed Fayaz, et al.
Publicado: (2020)

The Role of Statins in the Management of Patients Undergoing Coronary Artery Bypass Grafting
por: Siskos, Dimitrios, et al.
Publicado: (2018)

Quality of Life in Patients Undergoing Percutaneous Coronary Intervention
por: Tsoulou, Vasiliki, et al.
Publicado: (2023)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009)

Pre-existing depression in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Park, Jangho, et al.
Publicado: (2021)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

Local fluid dynamics in patients with bifurcated coronary lesions undergoing percutaneous coronary interventions
por: Genuardi, Lorenzo, et al.
Publicado: (2021)

Predictors of Inappropriately Rapid Coronary Lesion Progression in Patients Undergoing Percutaneous Coronary Interventions
por: Sella, Gal, et al.
Publicado: (2023)

Circulating Hematopoietic Stem/Progenitor Cells are Associated with Coronary Stenoses in Patients with Coronary Heart Disease
por: Zhu, Fu-Li, et al.
Publicado: (2019)

Coronary circulating mononuclear progenitor cells and soluble biomarkers in the cardiovascular prognosis after coronary angioplasty
por: Suárez‐Cuenca, Juan Antonio, et al.
Publicado: (2019)

Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients
por: Martínez, Gonzalo J., et al.
Publicado: (2017)

The effects of stenting on coronary endothelium from a molecular biological view: Time for improvement?
por: Cornelissen, Anne, et al.
Publicado: (2018)

Moderate-intensity versus high-intensity statin therapy in Korean patients with angina undergoing percutaneous coronary intervention with drug-eluting stents: A propensity-score matching analysis
por: Park, Mahn-Won, et al.
Publicado: (2018)

Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
por: Parikh, Shailja V, et al.
Publicado: (2009)

Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention
por: Pang, Zhihua, et al.
Publicado: (2017)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
por: De Luca, Leonardo, et al.
Publicado: (2022)

Coronary artery lesion distribution in patients with chronic kidney disease undergoing percutaneous coronary intervention
por: Ikeda, Naofumi, et al.
Publicado: (2022)

Factors contributing to exercise tolerance in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Li, Husheng, et al.
Publicado: (2023)

Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Wang, Man, et al.
Publicado: (2023)

Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study
por: De Luca, Leonardo, et al.
Publicado: (2022)

Intensive statin treatment ameliorate the Th17/Treg functional imbalance in patients with non‐ST elevation acute coronary syndrome underwent percutaneous coronary intervention
por: Ma, Xiaojing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c462c0atrvbncraqvlvq46drhd